Acute myocardial infarction associated with albuterol

Annals of Pharmacotherapy

Volumn 38, Issue 12, 2004, Pages 2045-2049

  Fisher, Alexander A ^a   Davis, Michael W ^a   McGill, Darryl A ^a,b  

^a CANBERRA HOSPITAL   (Australia)

^b The Australian National University   (Australia)

Author keywords

2 adrenoceptor agonist; Albuterol; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; AMIODARONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CAPTOPRIL; CARVEDILOL; CREATINE KINASE; IPRATROPIUM BROMIDE; OXYGEN; SALBUTAMOL; TROPONIN I;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONOTROPISM; CLINICAL FEATURE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE INJURY; HEART VENTRICULOGRAPHY; HUMAN; HYPOKALEMIA; HYPOKINESIA; INOTROPISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QT PROLONGATION; ST SEGMENT ELEVATION; THORAX DISEASE; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; AGED; AGED, 80 AND OVER; ALBUTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MYOCARDIAL INFARCTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 11944271550     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E150     Document Type: Article

References (26)

1. Libretto SE. A review of the toxicology of salbutamol (albuterol). Arch Toxicol 1994;68:213-6.
2. Ramsdell TW, Klinger NM, Ekholm BP, Colice GL. Safety of long-term treatment with HFA albuterol. Chest 1999;115:945-51.
3. Costello J. Cardiac effects of beta-agonists in patients with COPD (editorial). Chest 1998;114:353-4.
4. Szczeklik A, Nizankowski R, Mruk J. Myocardial infarction in status asthmaticus. Lancet 1977;1:658-9.
5. Santo M, Sidi Y, Pinkhas Y. Acute myocardial infarction following intravenous salbutamol (letter). S Afr Med J 1980;58:394.
6. Neville E, Corris PA, Vivian J, Nariman S, Gibson GJ. Nebulised salbutamol and angina. Br Med J 1982;285:796-7.
7. Beauvoir C, Sissman J. [Asymptomatic electrical myocardial necrosis during the infusion of betamimetics in status asthmaticus] French. Ann Fr Anesth Reanim 1988;7:511-4.
8. Shovlin CL, Tam FW. Salbutamol nebuliser and precipitation of critical cardiac ischaemia (letter). Lancet 1990;336:1258.
9. Vermes E, Leroy G, Halphen C, Guyon P, Labib M, Stoltz JP, et al. [Myocardial infarction in a pregnant woman during salbutamol therapy] French. Arch Mal Coeur Vaiss 1997;90:1651-4.
10. Montgomery HE, Gill J, Pumphrey CW. Unsuspected coronary artery disease revealed by administration of nebulised salbutamol. Br Heart J 1994;72:181.
11. Craig-McFeely PM, Wilton LV, Soriano JB, Maier WC, Shakir SA. Prospective observational cohort safety study to monitor the introduction of a non-CFC formation of salbutamol with HFA134a in England. Int J Clin Pharmacol Ther 2003;41:67-76.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
13. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
14. Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockcroft D, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149:604-10.
15. Coughlin SS, Metayer C, McCarthy EP, Mather FJ, Waldhorn RE, Gersh BJ, et al. Respiratory illness, beta-agonists, and risk of idiopathic dilated cardiomyopathy. The Washington, DC, Dilated Cardiomyopathy Study. Am J Epidemiol 1995;142:395-403.
16. Au DH, Udris EM, Fan VS, Curtis JR, McDonell MB, Fihn SD. Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. Chest 2003;123:1964-9.
17. Ben-Shlomo I, Zohar S, Marmor A, Blondheim DS, Sharir T. Myocardial ischaemia during intravenous ritodrine treatment: is it so rare (letter)? Lancet 1986;2:917-8.
18. Iskander SB, Mathai MG, Byrd RP Jr, Roy TM. Myocardial injury during standard treatment of an adult with status asthmaticus. J Asthma 2004;41:337-42.
19. Derreza H, Fine MD, Sadaniantz A. Acute myocardial infarction after use of pseudoephedrine for sinus congestion. J Am Board Fam Pract 1997;10:436-8.
20. Cockings JG, Brown M. Ephedrine abuse causing acute myocardial infarction. Med J Aust 1997;167:199-200.
21. Hall IP, Woodhead MA, Johnston ID. Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study. Respiration 1994;61:214-8.
22. Rossinen J, Partanen J, Stenius-Aarniala B, Nieminen MS. Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease. J Intern Med 1998;243:361-6.
23. Fowler MB, Timmis AD, Crick JP, Vincent R, Chamberlain DA. Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction. Br Med J 1982;284:73-6.
24. Lowe MD, Rowland E, Brown MJ, Grace AA. Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium. Heart 2001;86:45-51.
25. Braden GL, Germain MJ, Mulhern JG, Hafer JG Jr, Bria WF. Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients. Chest 1998;114:380-7.
26. 2-adrenoceptor stimulation on exercise-induced myocardial ischemia. Am J Cardiol 1991;68:111-4.